Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Clinical, Safety and Biomarker Results From the FENopta Open-Label Extension

Bar-Or, Amit; Oh, J.; Dufek, Michal; Budincevic, Hrvoje; Habek, Mario; Caunt, Maresa; Harp, C.; Sierzega, M.; Clayton, David; Chen, Y.; Ratchford, JN; Goodyear, Alexandra; Drulović, Jelena S.

Results

eNauka > Rezultati > Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Clinical, Safety and Biomarker Results From the FENopta Open-Label Extension

Naziv:	Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Clinical, Safety and Biomarker Results From the FENopta Open-Label Extension
Autori:	Bar-Or, Amit; Oh, J.; Dufek, Michal; Budincevic, Hrvoje; Habek, Mario; Caunt, Maresa; Harp, C.; Sierzega, M.; Clayton, David; Chen, Y.; Ratchford, JN; Goodyear, Alexandra; Drulović, Jelena S. ;
Godina:	2025
Publikacija:	Multiple sclerosis journal (ACTRIMS Forum 2025, Feb 27 - Mar 1, 2025, Florida, USA)
ISSN:	1352-4585 Multiple Sclerosis Pretraži identifikator
Izdavač:	London : SAGE Publications
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 31 br. 2 Suppl str. 66-67
WoS-ID:	001535085400142
URI:	https://enauka.gov.rs/handle/123456789/996999
URL:	https://journals.sagepub.com/doi/epub/10.1177/13524585251333228
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Google Scholar^TM